This study compared 3 systems and a newly designed stepwise discriminant diagnostic system (SDDS) to assess accuracy, reproducibility, and reliability in adrenocortical nodular hyperplasia
hyperplasia took into account the nodule size, pattern of distribution, color, and architectural pattern. The nodules compress the adjacent cortex and reveal clear cells, along with clusters of compact cells. Cellular hypertrophy and nuclear pleomorphism may be seen in some nodules. Examination of the adjacent cortex in nodular hyperplasia shows evidence of hyperplasia.
The clinical syndrome was studied in each case by the standard clinical, laboratory (including basal hormone determination, along with stimulatory and suppression tests, if necessary), and imaging methods. [12] [13] [14] 
Histopathologic Analysis
All microscopic slides were reviewed and used for systematic histologic evaluation by 2 independent observers (A.B. and S.J.D.-C.) who performed the evaluation in tumors and dominant adenomatous nodules of ACNH. In case of disagreement, the lesions were discussed during simultaneous inspection before final categorization. Reproducibility data were not recorded. Evaluation included the following:
1. The histologic pattern of the cortex adjacent to ACA and ACC was considered atrophic if architectural disarray and a thick, fibrous capsule were present in a thin cortex. The opposite features defined hyperplastic cortex, and the absence of those features was indicative of normal histologic features. 2. The lesion architecture was classified according to the growth pattern as alveolar, trabecular, nodular, insular, and diffuse or solid. 3. Necrosis was defined by dense eosinophilic cytoplasm and fragmented nuclei in a neutrophilic background. Its distribution pattern and extension (lesion percentage) were also surveyed. Lymphocytic satellitosis surrounding apoptotic cells was registered as peripolesis. 4. Tissue reaction, considering 2 main subtypes: desmoplastic (homogeneous hyaline connective tissue) and myxoid (basophilic loose extracellular matrix). When present, its extension was registered as lesion percentage. 5. Inflammation type and grade were separately considered. 6. Tumor capsule invasion (defined by tumor cell infiltration through the capsule). 7. Vascular and perineural invasion was evaluated as part of lesion extension. 8. Cytoplasmic features included staining (eosinophilic, basophilic, and pale), appearance (homogeneous, foamy, and granular), and the presence of globules or cytoplasmic pigment. 9. Nuclear features were independently analyzed as reported, 15 including nuclear size variability, pleomorphism, chromatin distribution, and nucleolus.
Nuclear grade was considered high if 3 or more nuclear features were present. 10. Nuclear/cytoplasmic (N/C) ratio (low or high) was referred to that of the corresponding cellular type (foamy, clear, and eosinophilic). 11. The mitotic figure count (MFC) was performed in 50 consecutive high-power fields (HPF) (5.232 mm 2 ) as reported. 16 [1] [2] [3] The systems were validated using an independent set of lesions (ACNH, 23; ACA, 37; ACC, 18) and calculating the percentage of cases correctly classified.
Statistical Analysis
Qualitative variables were compared by the Pearson χ 2 test (with Yates correction, if necessary) and the Fisher exact test, whereas quantitative variables were analyzed by nonparametric analysis of variance. Results were considered statistically significant if the P value was less than .05 in 2-tailed distribution assays.
Significant variables were introduced in several stepwise discriminant analyses using complete cases only, obtaining the corresponding discriminant function coefficients of each diagnostic group and the classification matrices. In addition, every discriminant analysis was validated by randomly subtracting 20 cases and then running new analyses with the remaining 172 cases. At least 10 cross-validation tests were performed for each diagnostic system. The multivariate analyses included the following: (1) Define a stepwise discriminant diagnostic system (SDDS) for ACNH, ACA, and ACC using the histologic features described in the preceding text. (2) Check the reproducibility of all diagnostic systems for the diagnosis of ACNH, ACA, and ACC.
Finally, contingency tables were used to calculate sensitivity, specificity, and predictive values for each diagnostic system in relation to ACC diagnosis, tumor diagnosis, and ACA diagnosis. Data are given as mean ± SD unless otherwise stated.
Results
The most frequent manifestations were Cushing syndrome for ACNH and mass with no endocrine symptoms for ACA and ACC ❚Figure 1❚; the simultaneous presence of endocrine symptoms and mass effect was suggestive of ACC. The only morphologic finding that correlated with the clinical manifestations was the presence of cortical atrophy in Cushing syndrome due to adrenocortical neoplasms.
Adrenocortical Nodular Hyperplasia
ACNHs were found in 69 females (84%) and 13 males (16%) with an age of 43.5 ± 14.3 years. The adrenals weighed 32.2 ± 35.7 g and showed a maximum diameter of 10.4 ± 4.6 cm.
Histologic examination revealed a trabecular growth pattern in 60 cases (73%), alveolar in 17 cases (21%), and nodular in 5 cases (6% (84%); inconspicuous nucleoli, 78 cases (95%); and low N/C ratio, 60 cases (73%). Only 4 cases (5%) showed nuclear pseudoinclusions, and 13 revealed multinucleated cells (16%). The MFC was low (0.44 ± 0.55 MF/50 HPF; 0.12 ± 0.22/1,000 cells) with no atypical MF.
Adrenocortical Adenoma
ACAs were found in 64 females (82%) and 14 males (18%) with an age of 45.5 ± 14.9 years. The adrenals weighed 47.9 ± 92.6 g, and the tumor measured 5.5 ± 3.0 cm in maximum diameter.
Histologically, the peritumoral gland was atrophic in 29 cases (37%), hyperplastic in 10 cases (13%), and unremarkable in 39 cases (50%). The growth pattern of the tumors was alveolar in 29 cases (37%), trabecular in 27 (35%), nodular in 20 (26%), and insular in 2 (3%). Cytologically, tumors composed of foamy, clear cells predominated in this series (46 cases [59%]), and only 20 cases (26%) contained eosinophilic globules. Twelve cases (15%) had pigment-containing cells.
Small necrotic foci were present in 5 cases (6%) and isolated apoptotic cells in 25 cases (32%). No or minimal inflammatory response was found, predominantly lymphocytic (51 cases [65%]). Myxoid stromal reaction was observed in 29 cases (37%) and desmoplastic tissue response in 5 cases (6%). Only 2 cases (3%) showed occasional intravascular cells through wall discontinuity and capsular disruption, but no perineural or lymphatic involvement was seen.
Nuclear 
Adrenocortical Carcinoma
ACCs were found in 23 females (72%) and 9 males (28%) with an age of 48.3 ± 19.2 years. The adrenals weighed 470.0 ± 590.8 g, and the tumor measured 12.0 ± 6.2 cm in maximum diameter.
Microscopically, the peritumoral gland was atrophic in 3 cases (9%), hyperplastic in 3 (9%), and unremarkable in 26 (82%). The growth patterns of the tumors were diffuse in 18 cases (56%), insular in 7 (22%), nodular in 5 (16%), and trabecular in 2 (6%). Cytologically, all tumors predominantly revealed eosinophilic cells, and 7 cases (22%) also showed eosinophilic globules. No pigment was seen.
Tumor cell necrosis was frequently observed (21 cases [66%]), with a confluent (14 cases [44%]) or perithelial pattern (7 cases [22%]). In addition, apoptotic cells were present in 25 cases (78%), associated with lymphocytic satellitosis in only 11 cases (34%). The inflammatory response was minimal in 23 cases (72%), predominantly lymphocytic in 16 cases (50%). A stromal reaction was observed in 21 cases (66%) and was desmoplastic in 19 (59%) and myxoid in 2 (6%). Local staging showed extracapsular extension in 16 cases (50%) and blood vessel invasion (capsular blood in 14 cases [44%] and extracapsular in 2 [6%]). Only 1 case showed perineural invasion, but no lymphatic invasion was observed.
Nuclear features included high grade in 30 cases (94%), prominent anisokaryosis in 32 (100%), severe pleomorphism in 30 (94%), coarse chromatin in 25 (78%), inconspicuous nucleoli in 25 (78%), and a low N/C ratio in 21 (66%). Nuclear pseudoinclusions were present in 7 cases (22%) and multinucleated cells in 11 (34%). The MFC was high (15.58 ± 0.53 MF/50 HPF; 3.52 ± 1.96/1,000 cells) with atypical MFs in 21 cases (66%; indexing 1.83 ± 2.98/50 HPF and 0.36 ± 0.61/1,000 cells). Fewer than 15% of ACC cases (4/32) had an SD MF/HPF of less than 0.24, whereas more than 95% of the benign lesions (154/160) had an SD MF/HPF of less than 0.29.
SDDS Definition
ACC was mainly defined by unremarkable peritumoral gland, diffuse or insular tumor growth pattern, eosinophilic cytoplasm in tumor cells, high nuclear grade (highly variable nuclear size and severe pleomorphism), and high SD MF/HPH , along with confluent necrosis and desmoplastic reaction ❚Table 2❚.
The SDDS independent predictors were SD MF/HPF , peritumoral gland pattern, anisokaryosis, and stromal reaction (presence and type) ❚Image 1❚, variables that were selected together in 70% or more of forthcoming cross-validation tests. Considering all variables as equally important, the probability of finding any of them (P) was .931 (P 5 = 0.7; therefore, P = .931). The percentage of correctly classified cases was always more than 88% ❚Table 3❚ and more than 92% when applying the initial set of criteria to the independent set of cases ❚Table 4❚.
Anisokaryosis and peritumoral adrenal pattern were always selected in the cross-validation tests, whereas SD MF/HPF and the stromal reaction (presence and type) were selected by 80% and 70% of cross-validations, respectively. If the MFC offered no diagnostic information, the pondered nuclear grade became the first alternative.
Other Systems
The HHS limits to diagnose ACNH, ACA, and ACC ❚Figure 2❚ meant that ACNH must not fulfill any criterion, although in this series, 4 ACNH cases showed moderate to severe pleomorphism (Table 1) . Similarly, ACA criteria would include moderate to severe pleomorphism, capsular invasion, and/or any of the following: tumor necrosis, broad fibrous bands, or mitotic index of more than 1/10 HPF, in decreasing importance. Although any histologic criterion was found in ACA, cases without nuclear pleomorphism or fulfilling more than 4 criteria were unlikely (Table 1) . ACC was diagnosed if the lesion showed moderate to severe pleomorphism, a mitotic index of more than 1/10 HPF, a diffuse growth pattern, and any of the remaining features (especially necrosis, broad fibrous bands, and capsular invasion), in decreasing order of relevance (Table 1) . No Hough criterion was ACC-specific. The percentages of cases correctly classified by the HHS are shown in ❚Table 5❚ and ❚Table 6❚.
WS and VSS discriminant function coefficients provided a narrow range for ACA diagnosis (Figure 2 ), explaining the ACNH diagnosis assigned to all benign lesions. Lack of clear cytoplasm and Fuhrman III/IV nuclear grade were the most frequent WS criteria in ACA; the others were found in fewer than 10% (Table 1) . VSS characterized ACA by moderate to severe nuclear atypia, moderate to severe hyperchromatism, and moderate to extensive regressive changes; tumor capsule invasion was found in tumors with no regressive changes ( Table 1) . ACC-specific criteria were the presence of atypical mitosis and 2 or more MF/10 HPF, whereas more than 5 MF/50 HPF and intravascular tumor cells were also found in ACA (Table 1) . ACC fulfilled several criteria (WS scores > 3 and VSS scores > 1.49), including moderate to severe pleomorphism and hyperchromatism, structural changes (diffuse growth pattern), and high mitotic indices (Table 1) . VSS regressive changes were frequent findings, whereas WS always revealed no clear cells. The percentages of cases correctly classified by the WS and VSS are shown in ❚Table 7❚ and ❚Table 8❚.
Reproducibility, Sensitivity, and Specificity Analyses
The sensitivity, specificity, and positive and negative predictive values are shown in ❚Table 9❚. Discriminant functions achieved high reproducibility with diagnostic agreement in 159/192 cases (82.8%); WS and VSS discriminant functions did not distinguish ACNH from ACA, restricting the reproducibility for these systems to the benign-malignant ACA, adrenocortical adenoma; ACC, adrenocortical carcinoma; ACNH, adrenocortical nodular hyperplasia.
Discussion
The diagnosis of adrenocortical proliferative lesions requires a combined and systematic evaluation. The single most important criterion of malignancy is intratumor MF variability, whereas the absence of positive histologic findings defines ACNH (with the exception of some nuclear atypia). Except for high and variable MFCs, any histologic feature can be present alone in ACA. The morphologic findings used to classify adrenocortical proliferative lesions were not predictive of the clinical syndrome.
The diagnostic usefulness of MF variability (SD MF/HPF ) has been hardly described for ACC diagnosis, although MFC is the most important diagnostic variable. 2, 3, 10, 11, [22] [23] [24] DNA and proliferation heterogeneity are hallmarks of malignant transformation in the adrenal cortex, 18 and, for the first time, this variability has been successfully incorporated in a diagnostic system as SD MF/HPF . SD MF/HPF was the most powerful malignancy predictor, with an SD MF/HPF of 0.30 or more (1 MF/HPF in 5 HPF, or at least 3 MF/50 HPF, 2 of them in a single HPF, screening 50 HPF) highly suggestive of malignancy (Image 1). Owing to the adrenocortical low proliferation index, accurate MF evaluation requires screening several HPF, but only the MFC has been used diagnostically. [1] [2] [3] Although MFC and SD MF/HPF are directly correlated, 18 the data variability was much higher for MFC, resulting in bigger group overlaps and less reliable classifications. 18 The diagnostic specificity increases by reducing the shadow areas, explaining the selection of SD MF/HPF for the SDDS and our proposal of SD MF/HPF evaluation in 50 HPF. Only an MFC of 2/10 HPF or more and the presence of atypical mitosis were ACC-specific 2,3 but were less sensitive (present in 63% of ACCs) and associated with other non-ACC-specific criteria, such as high nuclear grade, anisokaryosis, or desmoplastic reaction (Image 1). Only the HHS (broad fibrous bands) and VSS (as part of the regressive changes) have considered the desmoplastic reaction. 1, 3 Our discriminant study revealed no major diagnostic usefulness of local staging criteria. Defined by tumor cell nests within the fibrous capsule, 1-3 capsular invasion was present in 6% of ACAs and 69% of ACCs. However, capsular invasion became more specific when invasion through the capsule was required (Table 2) . Vascular invasion was normally associated with tumor capsule invasion, resulting in more specificity for malignancy if the vascular invasion was demonstrated in venous structures (2/78 ACAs and 12/32 ACCs).
SDDS defines ACNH by the absence of positive histologic features and, occasionally, some nuclear atypia. ACNH and ACA have shown overlapping histopathologic features, 12, 13 especially for multinodular glands with a dominant nodule. 25 The presence of a myxoid stromal reaction and anisokaryosis (Image 1) help distinguish ACNH from ACA, and their presence strongly suggests ACA. It is normally associated with dilated blood vessels, internal hemorrhage, edema, and atypical nuclei. 26 This reaction probably expresses a failure of the blood vessel to support tumor growth as proven by its presence in the biggest ACNH nodules, but only ACC has revealed a statistically significant increase of the vascular area. 27 Alternatively, perivascular stromal cells are key elements of epithelial cell growth by secretion of stimulatory factors or lack of inhibitory factors in endocrine gland nodules and tumors. 28, 29 The stromal reaction has been previously evaluated as regressive changes (including hemorrhage and fibrosis) in the VSS 3 and as fibrous bands in the HHS 1 ; WS does not evaluate it. 2 Atypical nuclei have been demonstrated DNA aneuploid and positive with in situ end labeling, 26, 30 suggesting they represent regressive changes that help distinguish ACA from ACNH only. 26, 31 These features have not been assessed in other systems.
There is no consensus on the evaluation of diagnostic variables like MFC, capsular invasion, regressive changes, stromal reaction, nuclear features, and local extension. These differences suggest that pathologists should become familiar with 1 or 2 diagnostic systems, especially for these relatively rare adrenocortical lesions. Our results revealed SDDS as the most specific, whereas the WS and VSS are the most sensitive for malignancy. For tumor diagnosis, the most sensitive was SDDS, and the WS, VSS, and SDDS were equally specific. These results recommend using SDDS and either WS or VSS when evaluating a potentially malignant adrenocortical lesion. The WS and VSS were developed to differentiate benign from malignant neoplasms, but they failed to distinguish ACNH from ACA. For this distinction, SDDS provided the best results, revealing only 7 ACAs (9%) misclassified as ACNH. These misclassified ACAs revealed a polyclonal pattern by human androgen receptor assay test in 6/7 females), regressive kinetics (low proliferation/relatively high apoptosis), and atypical nuclear features (5/6 cases) (data not shown). These clonal and kinetic patterns are more consistent with hyperplastic rather than neoplastic conditions, as SDDS has classified, 26 providing additional biologic meaning to the SDDS classification.
How should these results be applied for the diagnosis of adrenocortical lesions? We proposed the sequential application of statistically significant criteria that appear in ❚Figure 3❚, prioritizing by specificity.
MF/HPF variability is the most important malignancy criterion for adrenocortical lesions, but a systematic evaluation of multiple histologic parameters is required for accuracy. At least 2 diagnostic systems should be used to corroborate a malignant diagnosis: SDDS is the most specific, whereas WS and VSS are the most sensitive. SDDS is the most useful system to distinguish tumors from ACNH based on the analysis of myxoid stromal reaction and anisokaryosis.
